dc.contributor.author | Fresko, I. | |
dc.contributor.author | Yazici, H. | |
dc.contributor.author | UĞURLU, Serdal | |
dc.contributor.author | Yurdakul, S. | |
dc.contributor.author | Hamuryudan, V. | |
dc.contributor.author | Hatemi, G. | |
dc.contributor.author | Tukek, B. | |
dc.contributor.author | Esatoglu, S. N. | |
dc.contributor.author | Ozguler, Y. | |
dc.contributor.author | Melikoglu, M. | |
dc.contributor.author | Caliskan, E. B. | |
dc.date.accessioned | 2021-12-10T12:58:54Z | |
dc.date.available | 2021-12-10T12:58:54Z | |
dc.identifier.citation | Hatemi G., Tukek B., Esatoglu S. N. , Ozguler Y., Melikoglu M., Caliskan E. B. , UĞURLU S., Fresko I., Yurdakul S., Yazici H., et al., "INFLIXIMAB FOR VASCULAR INVOLVEMENT IN BEHCET SYNDROME", ANNALS OF THE RHEUMATIC DISEASES, cilt.80, ss.663, 2021 | |
dc.identifier.issn | 0003-4967 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_e60e7069-73ca-4f6a-b44f-4d66c3721df7 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/175137 | |
dc.identifier.uri | https://doi.org/10.1136/annrheumdis-2021-eular.3971 | |
dc.language.iso | eng | |
dc.subject | İç Hastalıkları | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | Rheumatology | |
dc.subject | Health Sciences | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ROMATOLOJİ | |
dc.title | INFLIXIMAB FOR VASCULAR INVOLVEMENT IN BEHCET SYNDROME | |
dc.type | Makale | |
dc.relation.journal | ANNALS OF THE RHEUMATIC DISEASES | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 80 | |
dc.identifier.startpage | 663 | |
dc.identifier.endpage | 663 | |
dc.contributor.firstauthorID | 2735436 | |